Patents
Patents for C07D 305 - Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms (5,442)
02/2004
02/12/2004WO2004012860A1 Catalyst and method for the carbonylation of oxiranes
02/12/2004US20040030164 Process for the preparation of taxan derivatives
02/12/2004US20040029976 1- Deoxy baccatin III, 1-deoxy taxol and 1-deoxy taxol analogs and method for the preparation thereof
02/12/2004US20040029812 Skin disorders; aging resistance
02/12/2004DE10235317A1 Katalysator und Verfahren zur Carbonylierung von Oxiranen Catalyst and process for the carbonylation of oxiranes
02/12/2004CA2741496A1 Methods and compositions for converting taxane amides to paclitaxel or other taxanes
02/12/2004CA2494074A1 Cytotoxic agents containing novel potent taxanes and their therapeutic use
02/11/2004EP1387844A1 Retinol derivatives potentiation of active substances by micellar preparation
02/11/2004CN1474703A Taxoid conjugates as antimitotic and antitumor agents
02/11/2004CN1473821A Method for extracting and purifying 10-desacetyl bakading III (10-DABIII)
02/05/2004US20040024051 C10 heterosubstituted acetate taxanes
02/05/2004US20040024049 Cytotoxic agents containing novel potent taxanes and their therapeutic use
01/2004
01/28/2004EP1384474A1 Injectable composition containing taxol
01/28/2004EP1383754A1 Process for making taxane derivatives
01/28/2004EP1383492A1 Molecular conjugates for use in treatment of cancer
01/28/2004CN1136207C Catalyst for preparing lactone and process for preparing lactone
01/27/2004US6683196 Reacting racemic beta-lactam with lithium- 7-protected baccatin iii- complex to form 3'desphenyl-3'-(1-napthyl)taxol; antitumor agents
01/27/2004US6683109 Condensation derivatives of thiocolchicine and baccatin as antitumor agents
01/27/2004CA2203844C Process for the isolation of paclitaxel and 9-dihydro-13-acetylbaccatin iii
01/22/2004WO2004007473A1 Process for preparing of paclitaxel
01/22/2004US20040014998 Process for the preparation of baccatin III derivatives
01/22/2004US20040014979 For use as antitumor agents
01/22/2004US20040013660 Synergistic mixtures
01/15/2004WO2002072010A3 Taxane prodrugs
01/14/2004EP1255745B1 Synthesis of water soluble 9-dihydro-paclitaxel derivatives from 9-dihydro-13-acetylbaccatin iii
01/08/2004WO2004003212A1 Novel process for the production of pancreatic lipase inhibitor
01/08/2004WO2004003102A2 Polymerizable, luminescent compounds and mixtures, luminescent polymer materials and their use
01/07/2004EP1378241A1 Pharmaceutical compositions comprising arsenic for the treatment of melanoma
01/07/2004EP1378240A2 Pharmaceutical compositions comprising arsenic for the treatment of multiple myeloma
01/07/2004EP1377291A2 1-butyric acid derivatives such as carbomethoxypropionyl cyanide or leflunomide derivatives, and the therapeutic use thereof
01/07/2004CN1133632C Process for preparation of taxanes from 10-deacetylbeccatin III
01/06/2004US6673948 Fluorinated oxetane derivatives and production process thereof
01/06/2004US6673947 Adding a 3-alkyloxetane methanol to a fluoroolefin under an alkali condition in a solvent and an alkali aqueous solution in presence of (tetrabutylammonium chloride) a phase transfer catalyst
01/06/2004US6673833 As antitumor agent
01/06/2004US6673780 Such as 4-(4-(3-hydroxy-3-methyl-butane-1-sulfinylmethyl)-phenylmethanesulfinyl)-2 -methyl-butan1-ol for treating and preventing cardiovascular diseases, dyslipidemias, dysproteinemias, and glucose metabolism disorders
01/06/2004CA2099232C Fluoro taxols
01/02/2004EP1374875A2 Pharmaceutical compositons comprising arsenic for the treatment of myelodysplastic syndrome
01/02/2004EP1372636A2 Metronomic dosing of taxanes for inhibiting tumor growth
12/2003
12/31/2003WO2004000922A1 Low acidity phosphate esters
12/31/2003WO2003030815A3 Method for the selective removal of acyl-functionality attached to the 2'-hydroxy-group of paclitaxel-related derivatives
12/31/2003CN1463969A Process for the manufacture of pacilitaxel nano granule
12/24/2003CN1462649A Tubular type reaction device for alcoholized propene chlorin
12/23/2003US6667330 Cytoprotective; neuroinflammation and neurodegenerative disorders; oxidative stress related conditions
12/18/2003US20030232878 For therapy of cancer
12/17/2003EP1370298A1 Elongated and multiple spacers in activatible prodrugs
12/16/2003US6664275 C10 heterosubstituted acetate taxanes
12/16/2003CA2157114C Process for the preparation of 9-desoxotaxanes
12/11/2003WO2002083067A3 Prodrugs via acylation with cinnamate
12/11/2003US20030229135 Method of preparation of anticancer taxanes using 3-[(substituted-2-trialkylsilyl)ethoxycarbonyl]-5-oxazolidine carboxylic acids
12/11/2003US20030228355 Precipitation of lipid; fineness particle size
12/10/2003EP1368328A1 Methods for preparing new taxoids and pharmaceutical compositions containing them
12/10/2003EP1368034A1 Method and dosage form for treating tumors by the administration of tegafur, uracil, folinic acid, paclitaxel and carboplatin
12/10/2003EP1178979B1 Novel reaction conditions for the cleavage of silyl ethers in the preparation of paclitaxel (taxol(r)) and paclitaxel analogues
12/10/2003EP0809639B1 Isolation and purification of paclitaxel and cephalomannine
12/10/2003CN1460720A Method for partial synthesis of taxal byt utilizing enzyme catalysis reaction
12/10/2003CN1130356C Partially synthetic seco-taxinane with antitumour activity
12/09/2003US6660866 C10 carbonate substituted taxanes
12/09/2003US6660344 A crosslinked polyether copolymer for liquid crystalline device; shrinkage inhibition
12/04/2003US20030225291 Mixing plant extracts with solvents, then filtering solids to remove impuritiesand drying to obtain anticarcinogenic agents; solvent extraction
12/03/2003EP1366024A2 Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses
12/03/2003EP0711158B1 Method of treating atherosclerosis or restenosis using microtubule stabilizing agent
12/02/2003US6656966 Nitrosated and nitrosylated taxanes, compositions and methods of use
11/2003
11/27/2003WO2003097625A1 Cytotoxic agents comprising polyethylene glycol-containing taxanes and their therapeutic use
11/27/2003WO2003097566A1 Method for the production of dialkyl diketenes
11/26/2003EP1363892A1 Stable pharmaceutical form of an anticancer drug
11/26/2003EP1363879A2 Sulfide and disulfide compounds and compositions for cholesterol management and related uses
11/26/2003EP0689436B1 Taxanes not having an oxo group at c-9 and pharmaceutical compositions containing same
11/26/2003CN1458151A Process for preparing high purity taxol by column bromating method
11/26/2003CN1128851C Coating composition comprising bicyclo- or spiro-orthoester-functional compound
11/26/2003CN1128795C Semi-synthetic taxane having anti-tumor activity
11/26/2003CN1128794C Taxad alcohol purifying method from its mixture with microtubular protein
11/25/2003US6653490 Process for the preparation of ammonium alkoxides
11/20/2003WO2003050154A3 Catalytic carbonylation of three and four membered heterocycles
11/19/2003CN1128224C Process for production of lipstation and tetraphydrolipstatin
11/19/2003CN1128014C Ag-CuCl catalyst for direct oxidation of propylene with air to prepare epoxypropane
11/18/2003US6649778 Methods of preparing amino acid taxane derivatives and polymer conjugates containing the same
11/18/2003US6649777 C2 substituted taxanes
11/18/2003US6649776 Producing alpha-methylenelactones by heating lactones with formaldehyde in supercritical fluid in presence of catalyst and phase transfer agent
11/18/2003US6649632 Exceptional utility as antitumor agents; bioavailability and nontoxic; oral administration; e.g., 10-propionyl-10-deacetyl Baccatin III; anticarcinogenic agents
11/18/2003CA2092849C Callus cell induction and the preparation of taxanes
11/13/2003US20030212294 Depolymerization polylactone using catalyst
11/12/2003EP1361222A1 Sidechain-bearing taxanes
11/11/2003US6646123 Antitumor
11/06/2003US20030208092 Reacting cyclopropylcarboxaldehyde and ketene in the presence of catalyst to polylactones used as chemical intermediates such as 3-cyclopropylacrylic acid, vinylcyclopropane or cyclopropylacetylene
11/06/2003US20030207888 Serotonin receptor agonists such as 6-chloro-4-methyl-1,2,3,4 -tetrahydro-2,4a,5-triaza-fluorene, used for prophylaxis of nervous system, cardiovascular, gastrointestinal, eating or sleep disorders, and as antidiabetic agents
11/05/2003EP0682660B1 Synthesis of taxol, analogs and intermediates with variable a-ring side chains
11/04/2003US6642271 Potentiating compounds
11/04/2003CA2091001C Baccatine iii derivatives
10/2003
10/30/2003WO2003048335A3 A fermentation process for lipstatin and method of extracting lipstatin from a fermentation broth
10/30/2003WO2003047531A3 Preparation of orlistat and orlistat crystalline forms
10/30/2003WO2003047508A3 Paclitaxel solvates
10/30/2003US20030203961 A taxane joined by a hydrolyzable bond to one or more oligomers that containing a polyethylene glycol group and a tert-amide group
10/29/2003EP0923566B1 High molecular weight polymer-based prodrugs
10/28/2003US6638973 Taxane formulations
10/28/2003CA2099200C Carbonylation of epoxides
10/23/2003WO2003087079A1 Conversion of taxane molecules
10/23/2003WO2003087078A1 Selective acylation of secondary hydroxyl groups
10/23/2003WO2003087077A1 A semi-synthetic process for the preparation of n­ debenzoylpaclitaxel
10/23/2003WO2003086394A1 Inhibitors of akt activity
10/22/2003CN1125061C C2 taxane derivatives and pharmaceutical compositions containing them
1 ... 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 ... 55